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Permanent Neonatal Diabetes Mellitus (PNDM) is a rare
disorder where patient presents with diabetes within the
first few months of life without autoantibodies asso-
ciated with type 1 diabetes. The majority of PNDM
cases have INS, ABCC8 or KCNJ11 mutations. We pre-
sent a PNDM case with INS mutation. The proband is a
second child of three siblings without family history of
diabetes. She was born at term via emergency lower seg-
ment caesarean section with good APGAR score. Her
birth weight was 2.0kg (<3rd percentile), length 49cm
(50th percentile), and head circumference 34cm (50th
percentile). She was discharged well at day 3 of life, but
readmitted at day 17 of life with hyperglycaemia, sepsis
and severe metabolic acidosis, requiring insulin infusion.
Despite clinical improvement and resolving sepsis, she
remained hyperglycaemic and hence neonatal diabetes
was suspected. Her GAD-65 and ICA-512 antibodies
were negative. HbA1c and c-peptide at diagnosis were
7.9% and 38 pmol/L (normal range: 297.9–1324) respec-
tively. She was still hyperglycaemic despite receiving
total daily insulin (TDI) of 1.5U/kg/day, but not ketotic.
She was discharged after 20 days of hospitalization with
insulatard administered three times daily (TDI 1.2U/kg/
day). During the first 8 months of diagnosis, her meta-
bolic control was good (HbA1c 6.7 - 7.6%) despite low
insulin requirement, as low as 0.4U/kg/day. Her meta-
bolic control deteriorated since then (HbA1c 11.9 -
13.2%), with TDI doses ranging 0.7 - 0.9 U/kg/day.
Rapid acting insulin was not used due to episodes of
hypoglycaemia and unpredictable eating habit and activ-
ity levels during her toddler years. Direct DNA sequen-
cing revealed she is heterozygous for p.A24D INS
mutation. This mutation has been reported in the litera-
ture and known to disrupt preproinsulin processing.
Recent evaluation at 51 month showed, negative anti-
islet cell antibodies and c-peptide of <30pmol/L (normal
range: 297.9–1324). Currently, her developmental mile-
stone is appropriate for her age. However, her height
and weight were both below the 3rd centiles. She was
recently started on insulin pump to improve her meta-
bolic control and growth.
Written informed consent was obtained from the
patient for publication of this abstract and any accompa-
nying images. A copy of the written consent is available
for review by the Editor of this journal.
Authors’ details
1Department of Molecular Medicine, Faculty of Medicine, University of
Malaya, Kuala Lumpur, Malaysia. 2Department of Pediatrics, Faculty of
Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Published: 28 April 2015
doi:10.1186/1687-9856-2015-S1-P29
Cite this article as: Long et al.: Permanent neonatal diabetes due to a
heterozygous INS mutation. International Journal of Pediatric Endocrinology
2015 2015(Suppl 1):P29.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
1Department of Molecular Medicine, Faculty of Medicine, University of
Malaya, Kuala Lumpur, Malaysia
Full list of author information is available at the end of the article
Long et al. International Journal of Pediatric Endocrinology 2015, 2015(Suppl 1):P29
http://www.ijpeonline.com/content/2015/S1/P29
© 2015 Long et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
